APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tacrolimus Market Analysis and Forecast 2026-2032

20 December 2025214 pages

Choose your research edition.

Industry ResearchTacrolimus Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tacrolimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Tacrolimus market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tacrolimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tacrolimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tacrolimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tacrolimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tacrolimus include GSK, Abbott, Takeda, Sichuan Med-Shine Pharmaceutical, Sandoz, Novartis, Mylan, Zhongmei Huadong Pharmaceutical and Hisun Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tacrolimus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tacrolimus, also provides the sales of main regions and countries. Of the upcoming market potential for Tacrolimus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tacrolimus sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tacrolimus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tacrolimus sales, projected growth trends, production technology, application and end-user industry.

Tacrolimus Segment by Company

GSK

Abbott

Takeda

Sichuan Med-Shine Pharmaceutical

Sandoz

Novartis

Mylan

Zhongmei Huadong Pharmaceutical

Hisun Pharmaceutical

Yamanouchi Pharmaceutical

Tecoland

Suzhou Pharmaceutical Technology

Squibb

Sinopharm Chuankang Pharmaceutical

Senju Pharmaceutical

ScinoPharm

RPG Life Science

Roche Pharma

Huapont Pharma

Guike Pharmaceutical

Fujisawa Pharmaceutical

Astellas

Accura Pharmaceuticals

Aarti Group

Tacrolimus Segment by Type

Tacrolimus Capsules

Tacrolimus Ointment

Tacrolimus Injection

Tacrolimus Segment by Application

Hospitals

Clinics

Other

Tacrolimus Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tacrolimus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tacrolimus sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tacrolimus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tacrolimus Capsules Major Manufacturers Table 3. Tacrolimus Ointment Major Manufacturers Table 4. Tacrolimus Injection Major Manufacturers Table 5. Global Tacrolimus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Other Major Manufacturers Table 9. Tacrolimus Industry Trends Table 10. Tacrolimus Industry Drivers Table 11. Tacrolimus Industry Opportunities and Challenges Table 12. Tacrolimus Industry Restraints Table 13. Global Tacrolimus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Tacrolimus Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Tacrolimus Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Tacrolimus Revenue Market Share by Region (2021-2026) Table 17. Global Tacrolimus Revenue Market Share by Region (2027-2032) Table 18. Global Tacrolimus Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Tacrolimus Sales by Region (2021-2026) & (K Tons) Table 20. Global Tacrolimus Sales by Region (2027-2032) & (K Tons) Table 21. Global Tacrolimus Sales Market Share by Region (2021-2026) Table 22. Global Tacrolimus Sales Market Share by Region (2027-2032) Table 23. Global Tacrolimus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Tacrolimus Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Tacrolimus Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Tacrolimus Sales Market Share by Manufacturers (2021-2026) Table 27. Global Tacrolimus Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Tacrolimus Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Tacrolimus Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Tacrolimus Manufacturers, Product Type & Application Table 31. Global Tacrolimus Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Tacrolimus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Tacrolimus Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Tacrolimus Revenue Market Share by Type (2021-2026) Table 38. Global Tacrolimus Revenue Market Share by Type (2027-2032) Table 39. Global Tacrolimus Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 40. Global Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 41. Global Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 42. Global Tacrolimus Sales Market Share by Type (2021-2026) Table 43. Global Tacrolimus Sales Market Share by Type (2027-2032) Table 44. Global Tacrolimus Price by Type (2021-2026) & (US$/Ton) Table 45. Global Tacrolimus Price by Type (2027-2032) & (US$/Ton) Table 46. Global Tacrolimus Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Tacrolimus Revenue Market Share by Application (2021-2026) Table 50. Global Tacrolimus Revenue Market Share by Application (2027-2032) Table 51. Global Tacrolimus Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 52. Global Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 53. Global Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 54. Global Tacrolimus Sales Market Share by Application (2021-2026) Table 55. Global Tacrolimus Sales Market Share by Application (2027-2032) Table 56. Global Tacrolimus Price by Application (2021-2026) & (US$/Ton) Table 57. Global Tacrolimus Price by Application (2027-2032) & (US$/Ton) Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. GSK Tacrolimus Product Portfolio Table 62. GSK Recent Development Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Abbott Tacrolimus Product Portfolio Table 67. Abbott Recent Development Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Takeda Tacrolimus Product Portfolio Table 72. Takeda Recent Development Table 73. Sichuan Med-Shine Pharmaceutical Company Information Table 74. Sichuan Med-Shine Pharmaceutical Business Overview Table 75. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio Table 77. Sichuan Med-Shine Pharmaceutical Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Sandoz Tacrolimus Product Portfolio Table 82. Sandoz Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Novartis Tacrolimus Product Portfolio Table 87. Novartis Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Mylan Tacrolimus Product Portfolio Table 92. Mylan Recent Development Table 93. Zhongmei Huadong Pharmaceutical Company Information Table 94. Zhongmei Huadong Pharmaceutical Business Overview Table 95. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio Table 97. Zhongmei Huadong Pharmaceutical Recent Development Table 98. Hisun Pharmaceutical Company Information Table 99. Hisun Pharmaceutical Business Overview Table 100. Hisun Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Hisun Pharmaceutical Tacrolimus Product Portfolio Table 102. Hisun Pharmaceutical Recent Development Table 103. Yamanouchi Pharmaceutical Company Information Table 104. Yamanouchi Pharmaceutical Business Overview Table 105. Yamanouchi Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Yamanouchi Pharmaceutical Tacrolimus Product Portfolio Table 107. Yamanouchi Pharmaceutical Recent Development Table 108. Tecoland Company Information Table 109. Tecoland Business Overview Table 110. Tecoland Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Tecoland Tacrolimus Product Portfolio Table 112. Tecoland Recent Development Table 113. Suzhou Pharmaceutical Technology Company Information Table 114. Suzhou Pharmaceutical Technology Business Overview Table 115. Suzhou Pharmaceutical Technology Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio Table 117. Suzhou Pharmaceutical Technology Recent Development Table 118. Squibb Company Information Table 119. Squibb Business Overview Table 120. Squibb Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Squibb Tacrolimus Product Portfolio Table 122. Squibb Recent Development Table 123. Sinopharm Chuankang Pharmaceutical Company Information Table 124. Sinopharm Chuankang Pharmaceutical Business Overview Table 125. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio Table 127. Sinopharm Chuankang Pharmaceutical Recent Development Table 128. Senju Pharmaceutical Company Information Table 129. Senju Pharmaceutical Business Overview Table 130. Senju Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Senju Pharmaceutical Tacrolimus Product Portfolio Table 132. Senju Pharmaceutical Recent Development Table 133. ScinoPharm Company Information Table 134. ScinoPharm Business Overview Table 135. ScinoPharm Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. ScinoPharm Tacrolimus Product Portfolio Table 137. ScinoPharm Recent Development Table 138. RPG Life Science Company Information Table 139. RPG Life Science Business Overview Table 140. RPG Life Science Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. RPG Life Science Tacrolimus Product Portfolio Table 142. RPG Life Science Recent Development Table 143. Roche Pharma Company Information Table 144. Roche Pharma Business Overview Table 145. Roche Pharma Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Roche Pharma Tacrolimus Product Portfolio Table 147. Roche Pharma Recent Development Table 148. Huapont Pharma Company Information Table 149. Huapont Pharma Business Overview Table 150. Huapont Pharma Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Huapont Pharma Tacrolimus Product Portfolio Table 152. Huapont Pharma Recent Development Table 153. Guike Pharmaceutical Company Information Table 154. Guike Pharmaceutical Business Overview Table 155. Guike Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 156. Guike Pharmaceutical Tacrolimus Product Portfolio Table 157. Guike Pharmaceutical Recent Development Table 158. Fujisawa Pharmaceutical Company Information Table 159. Fujisawa Pharmaceutical Business Overview Table 160. Fujisawa Pharmaceutical Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 161. Fujisawa Pharmaceutical Tacrolimus Product Portfolio Table 162. Fujisawa Pharmaceutical Recent Development Table 163. Astellas Company Information Table 164. Astellas Business Overview Table 165. Astellas Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 166. Astellas Tacrolimus Product Portfolio Table 167. Astellas Recent Development Table 168. Accura Pharmaceuticals Company Information Table 169. Accura Pharmaceuticals Business Overview Table 170. Accura Pharmaceuticals Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 171. Accura Pharmaceuticals Tacrolimus Product Portfolio Table 172. Accura Pharmaceuticals Recent Development Table 173. Aarti Group Company Information Table 174. Aarti Group Business Overview Table 175. Aarti Group Tacrolimus Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 176. Aarti Group Tacrolimus Product Portfolio Table 177. Aarti Group Recent Development Table 178. North America Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 179. North America Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 180. North America Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 181. North America Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 182. North America Tacrolimus Sales Price by Type (2021-2026) & (US$/Ton) Table 183. North America Tacrolimus Sales Price by Type (2027-2032) & (US$/Ton) Table 184. North America Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 185. North America Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 186. North America Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 187. North America Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 188. North America Tacrolimus Sales Price by Application (2021-2026) & (US$/Ton) Table 189. North America Tacrolimus Sales Price by Application (2027-2032) & (US$/Ton) Table 190. North America Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. North America Tacrolimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. North America Tacrolimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. North America Tacrolimus Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 194. North America Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 195. North America Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 196. North America Tacrolimus Sales Price by Country (2021-2026) & (US$/Ton) Table 197. North America Tacrolimus Sales Price by Country (2027-2032) & (US$/Ton) Table 198. United States Tacrolimus Revenue (2021-2032) & (US$ Million) Table 199. Canada Tacrolimus Revenue (2021-2032) & (US$ Million) Table 200. Europe Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 201. Europe Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 202. Europe Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 203. Europe Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 204. Europe Tacrolimus Sales Price by Type (2021-2026) & (US$/Ton) Table 205. Europe Tacrolimus Sales Price by Type (2027-2032) & (US$/Ton) Table 206. Europe Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 209. Europe Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 210. Europe Tacrolimus Sales Price by Application (2021-2026) & (US$/Ton) Table 211. Europe Tacrolimus Sales Price by Application (2027-2032) & (US$/Ton) Table 212. Europe Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Europe Tacrolimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Europe Tacrolimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Europe Tacrolimus Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 216. Europe Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 217. Europe Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 218. Europe Tacrolimus Sales Price by Country (2021-2026) & (US$/Ton) Table 219. Europe Tacrolimus Sales Price by Country (2027-2032) & (US$/Ton) Table 220. Germany Tacrolimus Revenue (2021-2032) & (US$ Million) Table 221. France Tacrolimus Revenue (2021-2032) & (US$ Million) Table 222. U.K. Tacrolimus Revenue (2021-2032) & (US$ Million) Table 223. Italy Tacrolimus Revenue (2021-2032) & (US$ Million) Table 224. Netherlands Tacrolimus Revenue (2021-2032) & (US$ Million) Table 225. China Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 226. China Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 227. China Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 228. China Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 229. China Tacrolimus Sales Price by Type (2021-2026) & (US$/Ton) Table 230. China Tacrolimus Sales Price by Type (2027-2032) & (US$/Ton) Table 231. China Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 232. China Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 233. China Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 234. China Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 235. China Tacrolimus Sales Price by Application (2021-2026) & (US$/Ton) Table 236. China Tacrolimus Sales Price by Application (2027-2032) & (US$/Ton) Table 237. Asia Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 238. Asia Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 239. Asia Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 240. Asia Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 241. Asia Tacrolimus Sales Price by Type (2021-2026) & (US$/Ton) Table 242. Asia Tacrolimus Sales Price by Type (2027-2032) & (US$/Ton) Table 243. Asia Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 244. Asia Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 245. Asia Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 246. Asia Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 247. Asia Tacrolimus Sales Price by Application (2021-2026) & (US$/Ton) Table 248. Asia Tacrolimus Sales Price by Application (2027-2032) & (US$/Ton) Table 249. Asia Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 250. Asia Tacrolimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 251. Asia Tacrolimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 252. Asia Tacrolimus Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 253. Asia Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 254. Asia Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 255. Asia Tacrolimus Sales Price by Country (2021-2026) & (US$/Ton) Table 256. Asia Tacrolimus Sales Price by Country (2027-2032) & (US$/Ton) Table 257. Japan Tacrolimus Revenue (2021-2032) & (US$ Million) Table 258. South Korea Tacrolimus Revenue (2021-2032) & (US$ Million) Table 259. India Tacrolimus Revenue (2021-2032) & (US$ Million) Table 260. Australia Tacrolimus Revenue (2021-2032) & (US$ Million) Table 261. China Taiwan Tacrolimus Revenue (2021-2032) & (US$ Million) Table 262. Southeast Asia Tacrolimus Revenue (2021-2032) & (US$ Million) Table 263. SAMEA Tacrolimus Revenue by Type (2021-2026) & (US$ Million) Table 264. SAMEA Tacrolimus Revenue by Type (2027-2032) & (US$ Million) Table 265. SAMEA Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 266. SAMEA Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 267. SAMEA Tacrolimus Sales Price by Type (2021-2026) & (US$/Ton) Table 268. SAMEA Tacrolimus Sales Price by Type (2027-2032) & (US$/Ton) Table 269. SAMEA Tacrolimus Revenue by Application (2021-2026) & (US$ Million) Table 270. SAMEA Tacrolimus Revenue by Application (2027-2032) & (US$ Million) Table 271. SAMEA Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 272. SAMEA Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 273. SAMEA Tacrolimus Sales Price by Application (2021-2026) & (US$/Ton) Table 274. SAMEA Tacrolimus Sales Price by Application (2027-2032) & (US$/Ton) Table 275. SAMEA Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 276. SAMEA Tacrolimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 277. SAMEA Tacrolimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 278. SAMEA Tacrolimus Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 279. SAMEA Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 280. SAMEA Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 281. SAMEA Tacrolimus Sales Price by Country (2021-2026) & (US$/Ton) Table 282. SAMEA Tacrolimus Sales Price by Country (2027-2032) & (US$/Ton) Table 283. Brazil Tacrolimus Revenue (2021-2032) & (US$ Million) Table 284. Argentina Tacrolimus Revenue (2021-2032) & (US$ Million) Table 285. Chile Tacrolimus Revenue (2021-2032) & (US$ Million) Table 286. Colombia Tacrolimus Revenue (2021-2032) & (US$ Million) Table 287. Peru Tacrolimus Revenue (2021-2032) & (US$ Million) Table 288. Saudi Arabia Tacrolimus Revenue (2021-2032) & (US$ Million) Table 289. Israel Tacrolimus Revenue (2021-2032) & (US$ Million) Table 290. UAE Tacrolimus Revenue (2021-2032) & (US$ Million) Table 291. Turkey Tacrolimus Revenue (2021-2032) & (US$ Million) Table 292. Iran Tacrolimus Revenue (2021-2032) & (US$ Million) Table 293. Egypt Tacrolimus Revenue (2021-2032) & (US$ Million) Table 294. Key Raw Materials Table 295. Raw Materials Key Suppliers Table 296. Tacrolimus Distributors List Table 297. Tacrolimus Customers List Table 298. Research Programs/Design for This Report Table 299. Authors List of This Report Table 300. Secondary Sources Table 301. Primary Sources List of Figures Figure 1. Tacrolimus Image Figure 2. Global Tacrolimus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tacrolimus Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tacrolimus Capsules Image Figure 5. Tacrolimus Ointment Image Figure 6. Tacrolimus Injection Image Figure 7. Global Tacrolimus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Tacrolimus Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Other Image Figure 12. Global Tacrolimus Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tacrolimus Revenue (2021-2032) & (US$ Million) Figure 14. Global Tacrolimus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Tacrolimus Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Tacrolimus Revenue Market Share by Region (2021-2032) Figure 17. Global Tacrolimus Sales (2021-2032) & (K Tons) Figure 18. Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 19. Global Tacrolimus Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Tacrolimus Sales YoY (2021-2032) & (K Tons) Figure 21. Europe Tacrolimus Sales YoY (2021-2032) & (K Tons) Figure 22. China Tacrolimus Sales YoY (2021-2032) & (K Tons) Figure 23. Asia (Excluding China) Tacrolimus Sales YoY (2021-2032) & (K Tons) Figure 24. South America, Middle East and Africa Tacrolimus Sales YoY (2021-2032) & (K Tons) Figure 25. Global Tacrolimus Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Tacrolimus Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Tacrolimus Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Tacrolimus Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Tacrolimus Revenue Market Share by Type (2021-2032) Figure 31. Global Tacrolimus Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 32. Global Tacrolimus Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Tacrolimus Sales Market Share by Type (2021-2032) Figure 34. Global Tacrolimus Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Tacrolimus Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Tacrolimus Revenue Market Share by Application (2021-2032) Figure 37. Global Tacrolimus Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 38. Global Tacrolimus Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Tacrolimus Sales Market Share by Application (2021-2032) Figure 40. North America Tacrolimus Revenue Share by Type (2021-2032) Figure 41. North America Tacrolimus Sales Share by Type (2021-2032) Figure 42. North America Tacrolimus Revenue Share by Application (2021-2032) Figure 43. North America Tacrolimus Sales Share by Application (2021-2032) Figure 44. North America Tacrolimus Revenue Share by Country (2021-2032) Figure 45. North America Tacrolimus Sales Share by Country (2021-2032) Figure 46. Europe Tacrolimus Revenue Share by Type (2021-2032) Figure 47. Europe Tacrolimus Sales Share by Type (2021-2032) Figure 48. Europe Tacrolimus Revenue Share by Application (2021-2032) Figure 49. Europe Tacrolimus Sales Share by Application (2021-2032) Figure 50. Europe Tacrolimus Revenue Share by Country (2021-2032) Figure 51. Europe Tacrolimus Sales Share by Country (2021-2032) Figure 52. China Tacrolimus Revenue Share by Type (2021-2032) Figure 53. China Tacrolimus Sales Share by Type (2021-2032) Figure 54. China Tacrolimus Revenue Share by Application (2021-2032) Figure 55. China Tacrolimus Sales Share by Application (2021-2032) Figure 56. Asia Tacrolimus Revenue Share by Type (2021-2032) Figure 57. Asia Tacrolimus Sales Share by Type (2021-2032) Figure 58. Asia Tacrolimus Revenue Share by Application (2021-2032) Figure 59. Asia Tacrolimus Sales Share by Application (2021-2032) Figure 60. Asia Tacrolimus Revenue Share by Country (2021-2032) Figure 61. Asia Tacrolimus Sales Share by Country (2021-2032) Figure 62. SAMEA Tacrolimus Revenue Share by Type (2021-2032) Figure 63. SAMEA Tacrolimus Sales Share by Type (2021-2032) Figure 64. SAMEA Tacrolimus Revenue Share by Application (2021-2032) Figure 65. SAMEA Tacrolimus Sales Share by Application (2021-2032) Figure 66. SAMEA Tacrolimus Revenue Share by Country (2021-2032) Figure 67. SAMEA Tacrolimus Sales Share by Country (2021-2032) Figure 68. Tacrolimus Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Tacrolimus Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tacrolimus Capsules
  • Tacrolimus Ointment
  • Tacrolimus Injection
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • GSK
  • Abbott
  • Takeda
  • Sichuan Med-Shine Pharmaceutical
  • Sandoz
  • Novartis
  • Mylan
  • Zhongmei Huadong Pharmaceutical
  • Hisun Pharmaceutical
  • Yamanouchi Pharmaceutical
  • Tecoland
  • Suzhou Pharmaceutical Technology
  • Squibb
  • Sinopharm Chuankang Pharmaceutical
  • Senju Pharmaceutical
  • ScinoPharm
  • RPG Life Science
  • Roche Pharma
  • Huapont Pharma
  • Guike Pharmaceutical
  • Fujisawa Pharmaceutical
  • Astellas
  • Accura Pharmaceuticals
  • Aarti Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tacrolimus Market by Type
  3. 1.2.1 Global Tacrolimus Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tacrolimus Capsules
  5. 1.2.3 Tacrolimus Ointment
  6. 1.2.4 Tacrolimus Injection
  7. 1.3 Tacrolimus Market by Application
  8. 1.3.1 Global Tacrolimus Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Tacrolimus Market Dynamics
  1. 2.1 Tacrolimus Industry Trends
  2. 2.2 Tacrolimus Industry Drivers
  3. 2.3 Tacrolimus Industry Opportunities and Challenges
  4. 2.4 Tacrolimus Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tacrolimus Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tacrolimus Revenue by Region
  3. 3.2.1 Global Tacrolimus Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tacrolimus Revenue by Region (2021-2026)
  5. 3.2.3 Global Tacrolimus Revenue by Region (2027-2032)
  6. 3.2.4 Global Tacrolimus Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tacrolimus Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tacrolimus Sales by Region
  9. 3.4.1 Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tacrolimus Sales by Region (2021-2026)
  11. 3.4.3 Global Tacrolimus Sales by Region (2027-2032)
  12. 3.4.4 Global Tacrolimus Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tacrolimus Revenue by Manufacturers
  2. 4.1.1 Global Tacrolimus Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tacrolimus Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tacrolimus Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tacrolimus Sales by Manufacturers
  6. 4.2.1 Global Tacrolimus Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tacrolimus Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tacrolimus Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tacrolimus Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tacrolimus Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tacrolimus Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tacrolimus Manufacturers, Product Type & Application
  13. 4.7 Global Tacrolimus Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tacrolimus Market CR5 and HHI
  16. 4.8.2 2025 Tacrolimus Tier 1, Tier 2, and Tier 3
5 Tacrolimus Market by Type
  1. 5.1 Global Tacrolimus Revenue by Type
  2. 5.1.1 Global Tacrolimus Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tacrolimus Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tacrolimus Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tacrolimus Sales by Type
  6. 5.2.1 Global Tacrolimus Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tacrolimus Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Tacrolimus Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tacrolimus Price by Type
6 Tacrolimus Market by Application
  1. 6.1 Global Tacrolimus Revenue by Application
  2. 6.1.1 Global Tacrolimus Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tacrolimus Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tacrolimus Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tacrolimus Sales by Application
  6. 6.2.1 Global Tacrolimus Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tacrolimus Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Tacrolimus Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tacrolimus Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Tacrolimus Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Abbott
  8. 7.2.1 Abbott Company Information
  9. 7.2.2 Abbott Business Overview
  10. 7.2.3 Abbott Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Tacrolimus Product Portfolio
  12. 7.2.5 Abbott Recent Developments
  13. 7.3 Takeda
  14. 7.3.1 Takeda Company Information
  15. 7.3.2 Takeda Business Overview
  16. 7.3.3 Takeda Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Takeda Tacrolimus Product Portfolio
  18. 7.3.5 Takeda Recent Developments
  19. 7.4 Sichuan Med-Shine Pharmaceutical
  20. 7.4.1 Sichuan Med-Shine Pharmaceutical Company Information
  21. 7.4.2 Sichuan Med-Shine Pharmaceutical Business Overview
  22. 7.4.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
  24. 7.4.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  25. 7.5 Sandoz
  26. 7.5.1 Sandoz Company Information
  27. 7.5.2 Sandoz Business Overview
  28. 7.5.3 Sandoz Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sandoz Tacrolimus Product Portfolio
  30. 7.5.5 Sandoz Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Tacrolimus Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Tacrolimus Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Zhongmei Huadong Pharmaceutical
  44. 7.8.1 Zhongmei Huadong Pharmaceutical Company Information
  45. 7.8.2 Zhongmei Huadong Pharmaceutical Business Overview
  46. 7.8.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
  48. 7.8.5 Zhongmei Huadong Pharmaceutical Recent Developments
  49. 7.9 Hisun Pharmaceutical
  50. 7.9.1 Hisun Pharmaceutical Company Information
  51. 7.9.2 Hisun Pharmaceutical Business Overview
  52. 7.9.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
  54. 7.9.5 Hisun Pharmaceutical Recent Developments
  55. 7.10 Yamanouchi Pharmaceutical
  56. 7.10.1 Yamanouchi Pharmaceutical Company Information
  57. 7.10.2 Yamanouchi Pharmaceutical Business Overview
  58. 7.10.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
  60. 7.10.5 Yamanouchi Pharmaceutical Recent Developments
  61. 7.11 Tecoland
  62. 7.11.1 Tecoland Company Information
  63. 7.11.2 Tecoland Business Overview
  64. 7.11.3 Tecoland Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Tecoland Tacrolimus Product Portfolio
  66. 7.11.5 Tecoland Recent Developments
  67. 7.12 Suzhou Pharmaceutical Technology
  68. 7.12.1 Suzhou Pharmaceutical Technology Company Information
  69. 7.12.2 Suzhou Pharmaceutical Technology Business Overview
  70. 7.12.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
  72. 7.12.5 Suzhou Pharmaceutical Technology Recent Developments
  73. 7.13 Squibb
  74. 7.13.1 Squibb Company Information
  75. 7.13.2 Squibb Business Overview
  76. 7.13.3 Squibb Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Squibb Tacrolimus Product Portfolio
  78. 7.13.5 Squibb Recent Developments
  79. 7.14 Sinopharm Chuankang Pharmaceutical
  80. 7.14.1 Sinopharm Chuankang Pharmaceutical Company Information
  81. 7.14.2 Sinopharm Chuankang Pharmaceutical Business Overview
  82. 7.14.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
  84. 7.14.5 Sinopharm Chuankang Pharmaceutical Recent Developments
  85. 7.15 Senju Pharmaceutical
  86. 7.15.1 Senju Pharmaceutical Company Information
  87. 7.15.2 Senju Pharmaceutical Business Overview
  88. 7.15.3 Senju Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Senju Pharmaceutical Tacrolimus Product Portfolio
  90. 7.15.5 Senju Pharmaceutical Recent Developments
  91. 7.16 ScinoPharm
  92. 7.16.1 ScinoPharm Company Information
  93. 7.16.2 ScinoPharm Business Overview
  94. 7.16.3 ScinoPharm Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 ScinoPharm Tacrolimus Product Portfolio
  96. 7.16.5 ScinoPharm Recent Developments
  97. 7.17 RPG Life Science
  98. 7.17.1 RPG Life Science Company Information
  99. 7.17.2 RPG Life Science Business Overview
  100. 7.17.3 RPG Life Science Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 RPG Life Science Tacrolimus Product Portfolio
  102. 7.17.5 RPG Life Science Recent Developments
  103. 7.18 Roche Pharma
  104. 7.18.1 Roche Pharma Company Information
  105. 7.18.2 Roche Pharma Business Overview
  106. 7.18.3 Roche Pharma Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Roche Pharma Tacrolimus Product Portfolio
  108. 7.18.5 Roche Pharma Recent Developments
  109. 7.19 Huapont Pharma
  110. 7.19.1 Huapont Pharma Company Information
  111. 7.19.2 Huapont Pharma Business Overview
  112. 7.19.3 Huapont Pharma Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Huapont Pharma Tacrolimus Product Portfolio
  114. 7.19.5 Huapont Pharma Recent Developments
  115. 7.20 Guike Pharmaceutical
  116. 7.20.1 Guike Pharmaceutical Company Information
  117. 7.20.2 Guike Pharmaceutical Business Overview
  118. 7.20.3 Guike Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Guike Pharmaceutical Tacrolimus Product Portfolio
  120. 7.20.5 Guike Pharmaceutical Recent Developments
  121. 7.21 Fujisawa Pharmaceutical
  122. 7.21.1 Fujisawa Pharmaceutical Company Information
  123. 7.21.2 Fujisawa Pharmaceutical Business Overview
  124. 7.21.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
  126. 7.21.5 Fujisawa Pharmaceutical Recent Developments
  127. 7.22 Astellas
  128. 7.22.1 Astellas Company Information
  129. 7.22.2 Astellas Business Overview
  130. 7.22.3 Astellas Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Astellas Tacrolimus Product Portfolio
  132. 7.22.5 Astellas Recent Developments
  133. 7.23 Accura Pharmaceuticals
  134. 7.23.1 Accura Pharmaceuticals Company Information
  135. 7.23.2 Accura Pharmaceuticals Business Overview
  136. 7.23.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
  138. 7.23.5 Accura Pharmaceuticals Recent Developments
  139. 7.24 Aarti Group
  140. 7.24.1 Aarti Group Company Information
  141. 7.24.2 Aarti Group Business Overview
  142. 7.24.3 Aarti Group Tacrolimus Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Aarti Group Tacrolimus Product Portfolio
  144. 7.24.5 Aarti Group Recent Developments
8 North America
  1. 8.1 North America Tacrolimus Market Size by Type
  2. 8.1.1 North America Tacrolimus Revenue by Type (2021-2032)
  3. 8.1.2 North America Tacrolimus Sales by Type (2021-2032)
  4. 8.1.3 North America Tacrolimus Price by Type (2021-2032)
  5. 8.2 North America Tacrolimus Market Size by Application
  6. 8.2.1 North America Tacrolimus Revenue by Application (2021-2032)
  7. 8.2.2 North America Tacrolimus Sales by Application (2021-2032)
  8. 8.2.3 North America Tacrolimus Price by Application (2021-2032)
  9. 8.3 North America Tacrolimus Market Size by Country
  10. 8.3.1 North America Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tacrolimus Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tacrolimus Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Tacrolimus Market Size by Type
  2. 9.1.1 Europe Tacrolimus Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tacrolimus Sales by Type (2021-2032)
  4. 9.1.3 Europe Tacrolimus Price by Type (2021-2032)
  5. 9.2 Europe Tacrolimus Market Size by Application
  6. 9.2.1 Europe Tacrolimus Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tacrolimus Sales by Application (2021-2032)
  8. 9.2.3 Europe Tacrolimus Price by Application (2021-2032)
  9. 9.3 Europe Tacrolimus Market Size by Country
  10. 9.3.1 Europe Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tacrolimus Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tacrolimus Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Tacrolimus Market Size by Type
  2. 10.1.1 China Tacrolimus Revenue by Type (2021-2032)
  3. 10.1.2 China Tacrolimus Sales by Type (2021-2032)
  4. 10.1.3 China Tacrolimus Price by Type (2021-2032)
  5. 10.2 China Tacrolimus Market Size by Application
  6. 10.2.1 China Tacrolimus Revenue by Application (2021-2032)
  7. 10.2.2 China Tacrolimus Sales by Application (2021-2032)
  8. 10.2.3 China Tacrolimus Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tacrolimus Market Size by Type
  2. 11.1.1 Asia Tacrolimus Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tacrolimus Sales by Type (2021-2032)
  4. 11.1.3 Asia Tacrolimus Price by Type (2021-2032)
  5. 11.2 Asia Tacrolimus Market Size by Application
  6. 11.2.1 Asia Tacrolimus Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tacrolimus Sales by Application (2021-2032)
  8. 11.2.3 Asia Tacrolimus Price by Application (2021-2032)
  9. 11.3 Asia Tacrolimus Market Size by Country
  10. 11.3.1 Asia Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tacrolimus Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tacrolimus Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tacrolimus Market Size by Type
  2. 12.1.1 SAMEA Tacrolimus Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tacrolimus Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tacrolimus Price by Type (2021-2032)
  5. 12.2 SAMEA Tacrolimus Market Size by Application
  6. 12.2.1 SAMEA Tacrolimus Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tacrolimus Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tacrolimus Price by Application (2021-2032)
  9. 12.3 SAMEA Tacrolimus Market Size by Country
  10. 12.3.1 SAMEA Tacrolimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tacrolimus Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tacrolimus Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tacrolimus Value Chain Analysis
  2. 13.1.1 Tacrolimus Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tacrolimus Production Mode & Process
  6. 13.2 Tacrolimus Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tacrolimus Distributors
  9. 13.2.3 Tacrolimus Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst